Skip to content
★ Sign in to follow
OB

Ozer Baysal

Executive
Total declarations
13
Company
1
▲ Purchases (1 ops.)
€6,115
▼ Sales (1 ops.)
€11k

Latest filing published 14 Dec 2017 for AGENUS INC, €40k.

Filing timeline

BuySale
Ozer Baysal

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 09 May 2016 · 3836 days ago · €6,115
    +12.8%
    Entry US$66.14 · Close at T+365 US$74.58

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Ozer Baysal: trading record in brief

This profile gathers the share dealings of Ozer Baysal in Agenus Inc. Between 2 January 2014 and 12 December 2017, the trades on record add up to 13 filings.

On the open market, the record shows 1 purchase worth €6,115 and 1 sale worth €11k. Netting one side against the other leaves €4,790 of net selling. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 8 share grants. Since January 2017: no purchases and 1 sale on the market.

The record was last updated on 14 December 2017 with an open-market sale (€11k) in Agenus Inc. The last insider purchase was made public on 9 May 2016, 3,836 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Ozer Baysal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ◆
    Chief Commercial OfficerExecutivesAgenus Inc
    46,957 USD13SEC
    13,080 shares@ US$3.5915.6% of flowCommon StockSEC:0001288123-17-000044:0
  • ▼
    Chief Commercial OfficerExecutivesAgenus Inc
    12,844 USD29SEC
    3,712 shares@ US$3.464.3% of flowCommon StockSEC:0001288123-17-000044:1
  • ◆
    Chief Business OfficerExecutivesAgenus Inc
    44,334 USD15SEC
    13,078 shares@ US$3.3916.2% of flowCommon StockSEC:0001288123-17-000023:0
  • ●
    Chief Business OfficerExecutivesAgenus Inc
    11,997 USD13SEC
    3,539 shares@ US$3.394.4% of flowCommon StockSEC:0001288123-17-000023:1
  • ◆
    Chief Business OfficerExecutivesAgenus Inc
    26,000 USD14SEC
    6,250 shares@ US$4.169.7% of flowCommon StockSEC:0001288123-17-000003:0
  • ◆
    Chief Business OfficerExecutivesAgenus Inc
    54,274 USD13SEC
    13,078 shares@ US$4.1518.8% of flowCommon stockSEC:0001288123-16-000070:0
  • ●
    Chief Business OfficerExecutivesAgenus Inc
    14,712 USD12SEC
    3,545 shares@ US$4.155.1% of flowCommon stockSEC:0001288123-16-000070:1
  • ▲
    Chief Business OfficerExecutivesAgenus Inc
    6,975 USD11SEC
    2,250 shares@ US$3.102.4% of flowCommon StockSEC:0001288123-16-000065:0
    Canonical exit: 3 Aug 2016 (T+90)
  • ◆
    Chief Business OfficerExecutivesAgenus Inc
    53,730 USD13SEC
    12,947 shares@ US$4.1518.6% of flowCommon StockSEC:0001288123-16-000062:0
  • ●
    Chief Business OfficerExecutivesAgenus Inc
    14,562 USD12SEC
    3,509 shares@ US$4.155.0% of flowCommon StockSEC:0001288123-16-000062:1
  • ◆
    Chief Business OfficerExecutivesAgenus Inc
    0SEC
    6,250 sharesCommon StockSEC:0001288123-16-000052:0
  • ◆
    CBOExecutivesAgenus Inc
    24,875 USD0SEC
    6,250 shares@ US$3.98Common StockSEC:0001288123-15-000001:0
  • ◆
    Chief Business OfficerExecutivesAgenus Inc
    17,375 USD0SEC
    6,250 shares@ US$2.78Common StockSEC:0001288123-14-000005:0

13 of 13 declarations